NAME OF MEDICATION

DOSAGE/FREQUENCY/ ROUTE

INDICATION

CONTRAINDICAT ION

SIDE EFFECTS / ADVERSE REACTION

NURSING INTERVENTION

 OXYTOCIN (Pitocin)

10 units of oxytocic
hormone/mL via IV infusion

Induction or

stimulation of labor;

Significant cephalopelvic disproportion; Unfavourable fetal positions or presentation; Obstetric emergencies that favour surgical intervention; Prolonged use in severe toxemia; Uterine inertia Hypertonic uterine patters Induction or augmentation of labor when vaginal birth is contraindicated Previous Cesarean Section delivery.

Control of postpartum bleeding;

Cardiac arrhythmias, Hypertension, Subarachnoid hemorrhage

Fetal bradycardia;

Ensure fetal position, size, and absence of complications that are contraindicated with oxytocin before therapy. Regulate rate of oxytocin delivery to establish uterine contractions that are similar to labor, fetal monitoring is preferred. Monitor the BP during oxytocin administration; discontinue drug and notify physician with any sign of hypertensive emergency.

As adjunctive

Neonatal jaundice; Low APGAR score

therapy in the management of incomplete or inevitable abortion.

Nausea; Vomiting Anaphylactic reaction

NAME OF

DOSAGE/FREQUENCY/

INDICATION

CONTRAINDICAT

SIDE EFFECTS /

NURSING

MEDICATION

ROUTE

ION

ADVERSE REACTION

INTERVENTION

METHYLERGONO
VINE MALEATE (Methergine)

IM:

0.2 mg after delivery of

placenta, after delivery of the anterior shoulder, or during puerperium.

Routine management after delivery of the placenta. Treatment of postpartum atony and hemorrhage; subinvolution of the uterus. Uterine stimulation during the second stage of labor following the delivery of the anterior shoulder, under strict medical supervision.

Contraindicated with allergy to methylergonovine, hypertension, toxemia, lactation, pregnancy. Use cautiously with sepsis, obliterate vascular disease, hepatic or renal impairment.

Dizziness, headache, tinnitus, diaphoresis. Hypertension, palpitations, chest pain, dyspnea. Nausea, vomiting.

Administer by IM injection or orally unless emergency requires IV use. Complications are more frequent with IV use. Monitor postpartum women for BP changes, amount, and character of vaginal bleeding. Discontinue if signs of toxicity occurs. Avoid prolonged use of the drug.

May be repeated every 24 hr IV: Same dosage as IM; infuse slowly over at least 60 sec. Monitor BP very carefully as severe hypertensive reaction may occur, reverse this route for emergency situations. ORAL: 0.2 mg PO tid or qid daily in the puerperium for up to 1 wk.

NAME OF MEDICATION

DOSAGE/FREQUENCY/ ROUTE

INDICATION

CONTRAINDICAT ION

SIDE EFFECTS / ADVERSE REACTION

NURSING INTERVENTION

PHYTOMENADIO
NE (Vitamin K, Phylloquinone, menaquinone)

0.1 cc via IM to the Vastus Lateralis of the newborn.

To stimulate the clotting factors of the newborn. To prevent hemorrhagic disease of the newborn.

Contraindicated to those who are hypersensitive to any component of Vitamin K containing products

The synthetic form of Vitamin K and Vitamin K3 (Menadione) can cause allergic reaction, Hemolytic Anemia, and Cytotoxicity in liver cells.

Ensure that the adequate dose is given while following the proper IM Drug Administration. Apply pressure to the injection site to prevent further bleeding. Document the giving of the medication to newborn to prevent an accidental doubling of the dose.

 OXYTETRACYCLI NE HCL (Terramycin Opthalmic Ointment, Terak, Terramycin with Polymyxin B)

1 cm strip applied from the inner canthus of the eye to the outer canthus

To prevent infection of the eye which may derive from flora or present infections of the vagina during normal spontaneous delivery To prevent Opthalmia neonatorum in infants.

None

Irritation Redness Tearing Iching sensation

None